April 29th 2025
The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
BIO 2024: Impact of Biosecure Act on the Pharma Industry
June 5th 2024Pharmaceutical Technology® spoke with Parviz Shamlou, senior vice-president of Science and Technology, Abzena, about the impact of the Biosecure Act on the bio/pharmaceutical industry, as well as the progress of continuous manufacturing in biopharma.